We also observed that HOXB1 expression was significantly lower in high-grade glioma tissues (HGG; WHO III and WHO IV) than in low-grade glioma tissues (LGG; WHO I and WHO II) (CGGA; Fig 1B). This evidence concerns the gene HOXB1 and central nervous system cancer.